![Innovations & Novel Approaches in IO Imaging & Assessing Responses](https://d38uvx7mib76ry.cloudfront.net/public/images/xihgw3jWpI8kF8uU97C6U5D2ByAPDUlqWSuBFNPB.png)
In this podcast:
You will hear a panel discussion moderated by Dr Annette Schmid, Takeda Pharmaceuticals from the 2020 IO360° Summit regarding innovations and novel approaches in IO imaging and assessing responses.
Panelists include:
- Gregory Goldmacher, MD, PhD, MBA, Merck
- S. Peter Eggleton, MD, FFPM, Merck KGaA
- Ron Korn, MD, PhD, Imaging Endpoints
- Matthew Silva, PhD, Invicro
To learn more about the Immuno-Oncology 360° Conference, please visit IO360Summit.com.
Related Podcasts
View All![Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development](https://d38uvx7mib76ry.cloudfront.net/public/images/B1auwoT8ay8rv3yuV4VCj1STzbGoy021dONMzRpa.png)
Unlocking ctDNA's Potential for Prognostic Stratification, Tumor Evolution Insights & Accelerated Drug Development
![Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process](https://d38uvx7mib76ry.cloudfront.net/public/images/AYpBueo73sCdV35PWH03VZAbzSTl5LAzpocI3Dw2.png)
Key Lessons from Manufacturing Cell-Based Immunotherapies to Accelerate Development and Process
![Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities](https://d38uvx7mib76ry.cloudfront.net/public/images/7vsSLL3HBWLTBtdS3MMK2xSWLQbAiFFpcrzUwzxk.png)
Targeting TGF Beta in IO: Mechanisms, Challenges and Opportunities
![Delivery Challenges from the Oncology Pipeline](https://d38uvx7mib76ry.cloudfront.net/public/images/KtKZ8eWZDTc3KHctMQwakc58erXkmiezGIWodFIR.png)